Avextra 10/10 Cannabis Extract in Sesame Linseed Oil Shows Promise
A Phase II randomized controlled trial evaluated Avextra 10/10 cannabis extract clinical trial for treating neurodegenerative diseases using a rigorous double-blind design. The study assessed both therapeutic benefits and safety profiles of this…
GLP-1 Receptor Agonists: Clinical Evidence & Outcomes in Alzheimer’s
The liraglutide Alzheimer clinical trial reveals promising neuroprotective effects of GLP-1 receptor agonists. This phase 2b study demonstrated cognitive benefits and reduced neuroinflammation. These findings suggest potential expanded use beyond…
Exploring Cannabinoid Ligands in Neurodegenerative Disease Management
Cannabinoid ligands neurodegenerative diseases research highlights their potential in anti-inflammatory and immunomodulatory roles. These ligands may offer disease-modifying perspectives in conditions like Alzheimer's and Parkinson's. Current evidence…
Dietary Bioactives in Alzheimer’s Disease: A Critical Appraisal of Clinical Trials and Future Directions
This review critically examines dietary bioactives alzheimer s disease clinical trials, focusing on cannabinoids and other compounds. It provides clinicians with an evidence-based assessment to distinguish promising treatments from marketing claims.…
Amyotrophic Lateral Sclerosis (ALS) and Medical Cannabis in Utah
Utah's amyotrophic lateral sclerosis cannabis guidelines provide a state-sanctioned framework for managing ALS symptoms with medical cannabis. These guidelines influence patient access and prescribing protocols. They represent growing recognition of…
CurePSP Leads Bipartisan Briefing to Boost PSP, CBD, and MSA Research
Rare neurodegenerative diseases research is critical for conditions like PSP, CBD, and MSA, which currently lack effective treatments. CurePSP convened a bipartisan congressional briefing to increase awareness and funding. This advocacy aims to…
CB2 Receptors in the Brain: A Promising but Unproven Anti-Inflammatory Target
CB2 receptor neuroinflammation is a promising target in neurodegenerative diseases such as Alzheimer's and Parkinson's. Preclinical studies show CB2 activation reduces brain inflammation and protects neurons. However, clinical evidence for CB2 receptor…
Understanding Corticobasal Degeneration at Pacific Neuroscience Institute
Corticobasal degeneration neuroprotection is a critical area of research due to the disease's devastating progression. Cannabis shows promise in symptom management and neuroprotective effects for this rare disorder. Understanding these potentials can aid…
3 Key Findings: Cannabis Alzheimer’s Treatment Study 2025
The cannabis Alzheimer's treatment study demonstrates significant cognitive improvement in patients over 26 weeks. Low-dose THC-CBD extract was effective and safe in this clinical trial. These findings highlight promising advances in dementia care.
5 Ways Cannabidiol Alzheimer’s Treatment Benefits Brain Health
Cannabidiol Alzheimer's treatment is gaining attention for its potential to support brain health. CBD offers neuroprotective benefits that may help delay cognitive decline. This article explores five key ways cannabidiol impacts Alzheimer's disease.